Scientists have started researching stem cell therapy as a possible new way to manage inflammatory bowel diseases (IBDs). This approach may be an option in the coming years for people with Crohn’s disease who don’t respond to other treatments
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gut that can lead to severe gastrointestinal symptoms, malnutrition, and complications such as fistulas and cancer. Mesenchymal stem/stromal cells (MSCs) are being investigated as a novel therapy for IBD and have been demonstrated to be safe and effective
Researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, deliver a biologic drug in response to inflammation.
Reviews 2022 body of scientific evidence on the safety and efficacy of stem cell therapy to treat rheumatic disease highlights the potential benefits of mesenchymal stem
cells (MSCs) – a type of stem cell – for the treatment of lupus.
This Phase II study of mesenchymal stem cells is an early step in determining whether stem cell treatments hold promise as a safe, effective alternative for people with lupus who do not benefit from current treatments.
Inflammatory bowel diseases (IBDs) represent a group of chronic inflammatory disorders of the gastrointestinal (GI) tract including ulcerative colitis (UC), Crohn’s disease (CD), and unclassified IBDs.
It is now clear that EBV must be contained and suppressed in order to relieve the pain and suffering of many persons with chronic pain. This column is an introduction to the critical involvement of EBV with several chronic pain conditions.
Article from Harvard on Stem Cells and Diabetes
UC David Study Shows Promise…This article reports on the 18-month results of a clinical trial for bemdaneprocel, a stem cell-derived therapy for Parkinson’s disease. The therapy showed positive results in safety, tolerability, and potential efficacy in restoring dopamine production.
This article details a study on human bone marrow-derived mesenchymal stem cells (hMSCs) for treating Crohn’s disease. The research showed promising results in mouse studies, demonstrating the potential of hMSCs to heal the intestinal lining and prompt a positive immunologic response.
The RHA.org - Your Trusted Guide to Regenerative Health
© 2024 All Rights Reserved.